Skip to main content
Have a personal or library account? Click to login
Formulation and optimization of fenofibrate lipospheres using Taguchi’s experimental design Cover

Formulation and optimization of fenofibrate lipospheres using Taguchi’s experimental design

Acta Pharmaceutica
Volume 63 (2013): Issue 1 (March 2013)
By:  and    
Open Access
|Mar 2013
References

References

  1. 1. G. Fricker, T. Kromp, A. Wendel, A. Blume, J. Zirkel, H. Rebmann, C. Setzer, R. O. Quinkert, F. Martin and C. M. Goymann, Phospholipids and lipid-based formulations in oral drug delivery,.(2010) 1469-1486; DOI: 10.1007/s11095-010-0130-x.
    Open DOISearch in Google Scholar
  2. 2. Y. C. Tseng, Y. Tabata, S. H. Hyon and Y. Ikada, In vitro toxicity test of 2 cyanoacrylate polymers by cell culture method,(1990) 1355-1367; DOI: 10.1002/jbm.820241007.
    Open DOISearch in Google Scholar
  3. 3. K. Lam, J. Schakenraad, H. Esselbrugge, J. Feijen and P. Nieuwenhuis, The effect of phagocytosis of poly(L -lactic acid) fragments on cellular morphology and viability,(1993) 1569-1577; DOI: 10.1002/jbm.820271214.
    Open DOISearch in Google Scholar
  4. 4. D. B. Masters and A. J. Domb, Liposphere local anesthetic timed-release for perineural site application,(1998) 1038-1045; DOI: 10.1023/A:1011978010724.
    Open DOISearch in Google Scholar
  5. 5. S. Toongsuwan, L. C. Li, B. K. Erickson and H. C. Chang, Formulation and characterization of bupivacaine lipospheres,.(2004) 57-65; DOI: 10.1016/j.bbr.2011.03.031.
    Open DOISearch in Google Scholar
  6. 6. A. J. Domb, Long acting injectable oxytetracycline-liposphere formulations,(1995) 271-278; DOI: 10.1016/0378-5173(95)00098-4.
    Open DOISearch in Google Scholar
  7. 7. B. Amarji, D. Raghuwanshi, S. Vyas and P. Kanaujia, Lipid nano spheres (LNSs) for enhanced oral bioavailability of amphotericin B: development and characterization,(2007) 264-269; DOI: 10.1166/jbn.2007.029.
    Open DOISearch in Google Scholar
  8. 8. A. Bhatia, B. Singh, V. Rani and O. Katare, Formulation, characterization, and evaluation of benzocaine phospholipid-tagged lipospheres for topical application,(2007) 81-89; DOI: 10.1166/jbn.2007.009.
    Open DOISearch in Google Scholar
  9. 9. T. Bekerman, J. Golenser and A. Domb, Cyclosporin nanoparticulate lipospheres for oral administration,.(2004) 1264-1270; DOI: 10.1002/jps.20057.
    Open DOISearch in Google Scholar
  10. 10. N. Sateeshbabu and K. Gowthamarajan, Manufacturing techniques of lipospheres: overview,(2011) 17-21.
    Search in Google Scholar
  11. 11, USP Convention, Rockville (MD) 2008, pp. 2145-2146.
    Search in Google Scholar
  12. 12. J. J. Sheng, P. J. Sirois, J. B. Dressman and G. L. Amidon, Particle diffusional layer thickness in a USP dissolution apparatus II: a combined function of particle size and paddle speed,(2008) 4815-4829; DOI: 10.1002/jps.21345.
    Open DOISearch in Google Scholar
  13. 13. T. Higuchi, Mechanisms of sustained action medications: theoretical analysis of rate of release of solid drugs dispersed in solid matrices,(1963) 1145-1149; DOI: 10.1002/jps. 2600521210.
    Search in Google Scholar
  14. 14. R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. A. Peppas, Mechanisms of solute release from porous hydrophilic polymers,(1983) 25-35; DOI: 10.1016/0378-5173(83) 90064-9.
    Search in Google Scholar
  15. 15. P. Röeschlau, E. Bernt and W. Gruber, Enzymatic determination of total cholesterol in serum,.(1974) 403-407.
    Search in Google Scholar
  16. 16. P. Fossati and L. Prencipe, Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide,(1982) 2077-2080.
    Open DOISearch in Google Scholar
  17. 17. K. D. Kim, D. N. Han and H. T Kim, Optimization of experimental conditions based on the Taguchi robust design for the formation of nano-sized silver particles by chemical reduction method,.(2004) 55-61; DOI: 10.1016/j.cej.2004.08.003.
    Open DOISearch in Google Scholar
  18. 18. L. Mu and S. S. Feng, Fabrication, characterization and in vitro release of paclitaxel (Taxol®) loaded poly(lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers,(2001) 239-254; DOI: 10.1016/S0168-3659(01)00440-0.
    Open DOISearch in Google Scholar
  19. 19. A. Dubey, P. Prabhu and J. V. Kamath, Nano structured lipid carriers: A novel topical drug delivery system,(2012) 705-714.
    Search in Google Scholar
  20. 20. M. Nasr, S. Mansour, N. D. Mortada and A. El. Shamy, Lipospheres as carriers for topical delivery of aceclofenac: Preparation, characterization and in vivo evaluation,.(2008) 154-162; DOI: 10.1208/s12249-007-9028-2.
    Open DOISearch in Google Scholar
  21. 21. M. Ozyazici, E. H. Gokçe and G. Ertan, Release and diffusional modeling of metronidazole lipidmatrices,(2006) 331-339; DOI: 10.1016/j.ejpb.2006.02.005.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/acph-2013-0008 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 71 - 83
Published on: Mar 12, 2013
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
fenofibrate,
lipospheres,
olive oil,
phospholipids,
sustained release
Related subjects:
Pharmacy,
Pharmacy, other

© 2013 Chopparapu Saroja, Palghat Krishnamani Lakshmi, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Volume 63 (2013): Issue 1 (March 2013)
Previous article
Next article